Literature DB >> 23459570

Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.

Ralph Hb Benedict1, Hanneke E Hulst, Niels Bergsland, Menno M Schoonheim, Michael G Dwyer, Bianca Weinstock-Guttman, Jeroen Jg Geurts, Robert Zivadinov.   

Abstract

BACKGROUND: Gray-matter (GM) atrophy is strongly predictive of cognitive impairment in multiple sclerosis (MS) patients. The thalamus is the region where the atrophy/cognition correlation is most robust. However, few studies have assessed diffusion tensor imaging (DTI) metrics within the thalamus.
OBJECTIVE: This study was designed to determine if thalamus white matter DTI predicts cognitive impairment after accounting for the effects of volume loss.
METHODS: We enrolled 75 MS patients and 18 healthy controls undergoing 3T brain magnetic resonance imaging (MRI). Thalamus volumes were calculated on 3D T1 images. Voxelwise analyses of DTI metrics were performed within the thalamic white matter tracts. Neuropsychological (NP) testing, acquired using consensus standard methods, contributed measures of memory, cognitive processing speed and executive function.
RESULTS: All cognitive tests were significantly predicted (R (2) =0.31, p<0.001) by thalamus volume after accounting for influence of demographics. Mean diffusivity was retained in regression models predicting all cognitive tests, adding from 7-13% of additional explained variance (p<0.02) after accounting for thalamus volume.
CONCLUSIONS: We confirm the significant role of thalamus atrophy in MS-associated cognitive disorder, and further report that subtle thalamus pathology as detected by DTI adds incremental explained variance in predicting cognitive impairment.

Entities:  

Keywords:  Multiple sclerosis; cognitive impairment; diffusion tensor imaging; mean diffusivity; thalamus

Mesh:

Year:  2013        PMID: 23459570     DOI: 10.1177/1352458513478675

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  26 in total

1.  Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study.

Authors:  Alvino Bisecco; Maria A Rocca; Elisabetta Pagani; Laura Mancini; Christian Enzinger; Antonio Gallo; Hugo Vrenken; Maria Laura Stromillo; Massimiliano Copetti; David L Thomas; Franz Fazekas; Gioacchino Tedeschi; Frederik Barkhof; Nicola De Stefano; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2015-04-14       Impact factor: 5.038

2.  Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.

Authors:  Tomas Uher; Jana Blahova-Dusankova; Dana Horakova; Niels Bergsland; Michaela Tyblova; Ralph H B Benedict; Tomas Kalincik; Deepa P Ramasamy; Zdenek Seidl; Jesper Hagermeier; Manuela Vaneckova; Jan Krasensky; Eva Havrdova; Robert Zivadinov
Journal:  J Neurol       Date:  2014-06-22       Impact factor: 4.849

3.  Genetic and environmental influences on mean diffusivity and volume in subcortical brain regions.

Authors:  Nathan A Gillespie; Michael C Neale; Donald J Hagler; Lisa T Eyler; Christine Fennema-Notestine; Carol E Franz; Michael J Lyons; Linda K McEvoy; Anders M Dale; Matthew S Panizzon; William S Kremen
Journal:  Hum Brain Mapp       Date:  2017-02-27       Impact factor: 5.038

4.  Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.

Authors:  Nina Wagenknecht; Birte Becker; Miriam Scheld; Cordian Beyer; Tim Clarner; Tanja Hochstrasser; Markus Kipp
Journal:  J Mol Neurosci       Date:  2016-08-04       Impact factor: 3.444

5.  Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.

Authors:  Michael Deppe; Julia Krämer; Jan-Gerd Tenberge; Jasmin Marinell; Wolfram Schwindt; Katja Deppe; Sergiu Groppa; Heinz Wiendl; Sven G Meuth
Journal:  Hum Brain Mapp       Date:  2016-02-27       Impact factor: 5.038

Review 6.  Clinical relevance of brain volume measures in multiple sclerosis.

Authors:  Nicola De Stefano; Laura Airas; Nikolaos Grigoriadis; Heinrich P Mattle; Jonathan O'Riordan; Celia Oreja-Guevara; Finn Sellebjerg; Bruno Stankoff; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

7.  The role of the thalamus and hippocampus in episodic memory performance in patients with multiple sclerosis.

Authors:  Katherine A Koenig; Stephen M Rao; Mark J Lowe; Jian Lin; Ken E Sakaie; Lael Stone; Robert A Bermel; Bruce D Trapp; Micheal D Phillips
Journal:  Mult Scler       Date:  2018-03-07       Impact factor: 6.312

8.  Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study.

Authors:  Niels Bergsland; Ferdinand Schweser; Michael G Dwyer; Bianca Weinstock-Guttman; Ralph H B Benedict; Robert Zivadinov
Journal:  Hum Brain Mapp       Date:  2018-06-19       Impact factor: 5.038

Review 9.  Causes, effects and connectivity changes in MS-related cognitive decline.

Authors:  Carolina de Medeiros Rimkus; Martijn D Steenwijk; Frederik Barkhof
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar

10.  Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis.

Authors:  E Mak; N Bergsland; M G Dwyer; R Zivadinov; N Kandiah
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-31       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.